FDA inspection
Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.: FDA inspection ending Feb 11, 2020
FDA inspection 1117609 · Voluntary Action Indicated (VAI) · Newark, DE
Key facts
| Inspection ID | 1117609 |
|---|---|
| Firm | Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. |
| FEI number | 2577603 |
| Address | 100 Hygeia Dr |
| City | Newark |
| State | DE |
| ZIP | 19713 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Feb 11, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data